Research programme: oral aminoglycosides - Galleon Pharmaceuticals

Drug Profile

Research programme: oral aminoglycosides - Galleon Pharmaceuticals

Alternative Names: Amikacin oral - Galleon Pharmaceuticals; GALL 100; Oral aminoglycosides research programme - Galleon Pharmaceuticals

Latest Information Update: 06 Jan 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Galleon Pharmaceuticals
  • Class
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Gram-negative infections

Most Recent Events

  • 22 Jun 2005 Preclinical trials in Gram-negative infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top